You are currently viewing a new version of our website. To view the old version click .
Animals
  • Review
  • Open Access

16 October 2024

Molecular Factors Involved in the Pathogenesis of Pyometra in Domestic Cats (Felis catus)

,
and
Centro de Microscopia Eletronica, Departamento de Ciencias Biologicas, Universidade Estadual de Santa Cruz, Campus Soane Nazare de Andrade, Ilheus 45662-900, Brazil
*
Author to whom correspondence should be addressed.
This article belongs to the Special Issue Reproduction of Small Animals: Physiology, Pathology and Performance, Second Edition

Simple Summary

This article reviews the molecular factors causing pyometra in domestic cats, a serious uterine infection. While well-studied in dogs, pyometra in cats is less understood. The focus is on hormonal, redox, immunological, and growth factors, aiming to improve the diagnosis and treatment of the disease.

Abstract

Pyometra is a major reproductive disorder affecting female cats. Characterized by the accumulation of purulent exudate in the uterus, it can lead to severe and potentially fatal complications. This pathology primarily occurs in adult cats during diestrus, but can also affect younger felines, often due to inappropriate administration of hormonal medications. While the etiopathogenesis of pyometra is better understood in bitches, few studies have addressed the molecular factors involved in feline pyometra. Therefore, this review aims to provide an up-to-date and comprehensive discussion of pyometra in cats, focusing on the regulation of molecular factors described in this species, including hormonal, redox, immunological, and growth factors. Understanding the regulation of these factors in pyometra is crucial for elucidating its pathogenesis in domestic cats and for improving diagnosis and identifying novel therapeutic approaches.

1. Introduction

Pyometra is a severe inflammatory condition affecting domestic cats, considered one of the most concerning reproductive diseases in felines [,]. This disorder is characterized by the accumulation of purulent exudate in the uterus [], resulting from endometrial gland dilation, cystic structure formation, and accumulation of inflammatory cells, primarily neutrophils, macrophages, and lymphocytes [,]. In some cases, bacterial colonies associated with the inflammatory process can be identified [,]. Endometrial cells may exhibit signs of degeneration, and in chronic cases, fibrosis and proliferation of connective tissue in the uterine stroma may occur [,]. Pyometra presents a significant challenge for veterinarians and pet owners due to its insidious nature and potentially fatal outcomes, emphasizing the need for immediate medical intervention [,,].
Pyometra is frequently diagnosed based on clinical signs observed by pet owners, including polydipsia, polyuria, lethargy, loss of appetite, vomiting, abnormal vaginal discharge, and abdominal distension [,]. These signs may be confused with other medical conditions, making accurate diagnosis crucial for effective treatment. Moreover, pyometra often requires emergency care, such as removal of the infected uterus and treatment of associated systemic infection []. Despite the severity of the condition, studies on surgical outcomes for queens treated with ovariohysterectomy (OHE) demonstrate highly favorable results []. Pailler et al. [,] reported a 100% survival rate to hospital discharge, with most queens recovering fully. Long-term outcomes are equally positive, with no significant reduction in life expectancy, even in older queens or those with comorbidities like mammary tumors or heart disease. However, severe cases involving uterine rupture may lead to peritonitis and sepsis, both life-threatening complications that can result in long-term sequelae such as infertility [,,].
The disease primarily occurs in adult females during diestrus (Figure 1a), although it can also affect younger cats, often due to inappropriate administration of hormonal medications [,,]. However, other factors, such as genetic predisposition and reproductive history, such as spontaneous ovulation, may play a significant role in its occurrence [,].
Figure 1. Schematic representation of the domestic cat estrous cycle and pyometra development. (a) Reproductive cycle of cats. The cycle begins with proestrus, followed by estrus, characterized by male receptivity and elevated E2 levels. Without ovulatory stimulus or spontaneous ovulation (1), cats return to proestrus, potentially experiencing brief interestrus or anestrus periods. In ovulatory cycles (2 and 3), fertilization may occur, resulting in pregnancy (2), lasting 63–65 days; without fertilization (3), cats enter diestrus, a luteal phase. Post-pregnancy and lactation, or after diestrus, cats return to proestrus through interestrus intervals or seasonal anestrus. (b) Hormonal factors favoring bacterial proliferation and pyometra development. During proestrus and estrus, increased E2 causes uterine sensitization and cervical opening, while in diestrus, increased P4 results in uterine relaxation, increased glandular secretion, anti-inflammatory action, and cervical closure. (c) Photomicrographs of uterus with grade 3 pyometra. Lower magnification: uterine cross-section showing glandular hyperplasia and ectasia (arrows) and interstitial inflammatory infiltrate (arrowhead) with pus accumulation in the uterine lumen (asterisk). Higher magnification (inset): glandular (asterisk) and interstitial (arrow) infiltration of neutrophils, lymphocytes, and macrophages. E2, estradiol; P4, progesterone; scale bar = 100 μm.
While data on occurrence, epidemiological profile, and clinical aspects of pyometra in cats are well-established, much remains to be elucidated regarding the molecular factors contributing to the disease’s development. Recent findings have revealed alterations in numerous factors involved in angiogenesis and inflammatory response within the uterus of cats with pyometra [], potentially crucial for understanding the mechanisms underlying uterine infection. Given their potential as models for endangered wild felids [,], the study of reproductive diseases in domestic cats, such as pyometra, holds significant importance and warrants further investigation into associated mechanisms. This review aims to provide a comprehensive and up-to-date discussion of feline pyometra, exploring the molecular factors potentially involved in uterine and systemic alterations in affected animals.

2. Reproductive Cycle of Domestic Cats

The estrous cycle in female cats is divided into five distinct phases: proestrus, estrus, interestrus, diestrus, and anestrus (Figure 1a) [,]. However, variations in this presentation may occur due to their induced ovulation []. During proestrus, ovarian follicles begin to develop in response to follicle-stimulating hormone (FSH), resulting in a gradual increase in estradiol (E2) in preparation for estrus []. Estrus is the heat period characterized by receptive behaviors towards males and acceptance of coitus, with plasma E2 peaks exceeding 20 pg/mL []. Ovulation is generally induced by various stimuli, primarily tactile (Figure 1a), and occurs less frequently spontaneously [,]. If ovulation does not occur, cats may return to proestrus after a short interestrus period, or enter anestrus if under well-defined seasonal conditions (Figure 1a) [,]. If an ovulatory stimulus is followed by fertilization, cats become pregnant, with gestation lasting between 63 and 65 days [,] and plasma progesterone (P4) levels ranging from ~5.1 to 7.8 ng/mL between days 30 and 60 of pregnancy []. If fertilization does not occur after ovulation, cats enter diestrus (Figure 1a), a phase in which plasma P4 is also elevated due to corpus luteum formation [,]. During this period, cats are more susceptible to pyometra development due to elevated P4 levels []. After gestation (+lactation) or diestrus, cats typically return to proestrus following intervals of interestrus or seasonal anestrus (Figure 1a) [,].

3. Pyometra in Domestic Cats

Pyometra is one of the most prevalent reproductive diseases in female cats and can lead to sequelae for the animal, such as infertility and, in some cases, death [,,,,]. It is characterized by the accumulation of inflammatory infiltrate, primarily neutrophils, lymphocytes, and macrophages (Figure 1c). Frequently, there may be fibrin exudation characterized by eosinophilic fibrillar material [,,].
Based on histopathological characteristics, and the progression of the disease, pyometra in dogs and cats can be classified into four types, depending on the degree of pathological involvement and inflammatory infiltrate: type 1: endometrial hyperplasia without evidence of inflammatory process; type 2: endometrial hyperplasia accompanied by interstitial endometritis with mononuclear cells; type 3: exacerbation of endometrial inflammatory process, with neutrophil infiltration in the uterine lumen and endometrial glands (Figure 1c; asterisk); type 4: chronic endometritis with endometrial hypotrophy due to accumulation of inflammatory cells in the uterine lumen and, in some cases, squamous metaplasia of the epithelium [,].
In some cases of pyometra, ulceration of the endometrial epithelium may occur because of chronic inflammation and tissue damage. Additionally, epithelial and myometrial hypotrophy can develop when the accumulation of exudate in the uterine lumen increases pressure, compressing the epithelial cells and leading to their degeneration and reduction in size [,]. This process compromises the integrity and function of the endometrial epithelium, further exacerbating the inflammatory condition and contributing to more severe sequelae, such as reproductive dysfunction and infertility [,,].
In types 3 and 4, cellular debris and mucinous material are commonly observed in the tissue. The superficial layers of the endometrium may occasionally exhibit reactions similar to those observed during pregnancy, such as decidual reaction and papilliform projections formation, a condition known as pseudoplacental hyperplasia [,]. Other findings include glandular hyperplasia and ectasia, characterized by an increase in the number and dilation of endometrial glands, as well as the presence of cysts in these glands, known as cystic endometrial hyperplasia (CEH) [,,,]. Furthermore, congestion and hyperemia in blood vessels are common observations. Lymphatic vessel ectasia may also be present. In more advanced cases, the inflammatory infiltrate can extend to the myometrium and perimetrium [,,]. Figure 1c depicts a uterine lumen with superficial and deep endometrium, showing a marked inflammatory infiltrate predominantly lymphoplasmacytic, with intact and degenerated neutrophils, interspersed with eosinophilic fibrillar material, cellular debris, and weakly basophilic mucinous material. The infiltrate frequently extends to the epithelium and lumen of endometrial glands, which are sometimes ectatic and cystic, with hypertrophy of the lining epithelium.
Despite being a clinically significant reproductive disorder in cats, pyometra is reported more frequently in dogs [,,]. This discrepancy likely stems from differences in luteal phase duration between the two species, variability in ovulation occurrence in domestic cats, as well as underdiagnosis and non-specific clinical signs in felines [,]. Generally, cats only ovulate following a sufficient luteinizing hormone (LH) surge triggered by vaginal stimulation during mating (Figure 1a) [,,].
Various risk factors are associated with the occurrence of pyometra in cats. Age plays a significant role, with pyometra being more common in older, intact female cats over five years of age that experience regular and irregular hormonal cycles, although it can also affect younger cats. In the latter, it is typically associated with the exogenous administration of sex steroids as a contraceptive method [,,]. Furthermore, the stage of the reproductive cycle is a determining factor, and pyometra is frequently diagnosed during diestrus when P4 levels are elevated [,,]. Reproductive history is suggested to be a risk factor, as cats that have experienced multiple pregnancies, pseudopregnancies, or abortions may have a higher likelihood of developing pyometra [,]. In addition, the occurrence of spontaneous ovulation plays an important role in the pathogenesis of pyometra. While queens are considered induced ovulators, spontaneous ovulation has been reported, especially in certain circumstances of frequent sexual activity without copulation or hormonal imbalances [,]. This spontaneous ovulation can lead to prolonged luteal phases and elevated P4 levels, which create a favorable environment for bacterial proliferation in the uterus. P4 is known to reduce the immune response in the uterus, increase cervical closure, and promote endometrial glandular secretion, all of which contribute to the development of pyometra [].
Breed predisposition in cases of pyometra in queens has been increasingly recognized, with certain purebred cats showing a higher risk of developing the condition [,]. Studies indicate that Sphynx cats are particularly susceptible, along with other breeds such as Siberian, Ocicat, Korat, Siamese, Ragdoll, Maine Coon, and Bengal. This suggests a possible genetic predisposition, supported by observations of familial clusters of the disease in geographically isolated populations []. However, data on the incidence of spontaneous ovulation within these breeds are still limited, and further studies are needed to explore its potential role in familial clustering and breed susceptibility.
Furthermore, the uterine microbiome plays an important role in the pathogenesis of pyometra, as reported in a study on bitches []. Alterations in microbial composition may facilitate bacterial colonization and proliferation in the uterus [,]. A recent study demonstrated that proteins in the uterine tissues of female dogs with pyometra exhibit different glycosylation patterns compared to healthy uterine tissues []. These findings suggest that proteins in the uterus of dogs with pyometra are glycosylated differently, which may impact the normal functions of uterine cells, potentially leading to a variety of pathological reactions, including altered cell communication and signaling [,]. Altered expression of glycoconjugates in the endometrial epithelium may therefore be a key factor in facilitating bacterial invasion, contributing to the development of pyometra [,]. However, studies in cats are needed to elucidate the role of the uterine microbiome in the development of pyometra.

4. Etiopathogenesis

The primary cause of pyometra in cats is related to uterine predisposition to bacterial colonization due to increased levels of E2 during the estrus phase and P4 during diestrus (Figure 1b) [,] Under cyclic conditions, increased E2 is essential for the proliferation of uterine glands. However, unusual elevation of E2 can cause cystic endometrial hyperplasia (CEH) and increase uterine sensitivity to P4 (Figure 1b) []. Additionally, stimulation of the cervical opening may allow ascending colonization by vaginal bacteria, making the uterus more susceptible to bacterial infection (Figure 1b) [,,,]. When P4 levels rise, uterine relaxation, decreased myometrial contractions, and cervical closure occur, creating a favorable environment for bacterial growth (Figure 1b) [,,]. This combination of factors promotes the development of pyometra in dogs and cats [,,].
Endocrine disturbances in the endometrium are recognized as risk factors, particularly for the development of CEH. This condition results in undesirable morphological and functional changes, primarily affecting the endometrial glands. Furthermore, excessive mucus secretion creates favorable conditions for abundant bacterial growth within the uterine lumen, as seen in bitches [,].
Bacteria play a crucial role in the etiopathogenesis of pyometra; uropathogenic Escherichia coli (E. coli) is the most frequently isolated Gram-negative bacterium from the uteri of cats and dogs with pyometra [,]. Furthermore, this microorganism is demonstrated to be the most isolated strain in the lower reproductive tract of healthy female cats. Other bacteria may also be involved in the development of pyometra, such as Streptococcus spp., Staphylococcus spp., Pseudomonas spp., Proteus spp., Enterobacter spp., Nocardia spp., Pasteurella spp., and Klebsiella spp. [,,,,].

6. Conclusions

Pyometra in cats is a severe reproductive disease that still requires a better understanding of its epidemiology, etiopathogenesis, and progression. While numerous studies have been conducted in dogs, there remains a significant knowledge gap regarding this condition specifically in felines. Furthermore, research evaluating the molecular aspects involved in the development and pathogenesis of this disease in cats is necessary, as it will enable the development of more effective prevention, diagnostic, and treatment strategies.

Author Contributions

A.E.d.J.N., L.C.S., and J.F.S. contributed to the design and writing of the manuscript. J.F.S. revised the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by Universidade Estadual de Santa Cruz (UESC).

Institutional Review Board Statement

Not applicable. This study did not involve humans or animals.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Satilmis, F. Pyometra in Queens—Changes in Haemato-Biochemical Parameters. Acta Sci. Vet. 2023, 51, 1–10. [Google Scholar] [CrossRef]
  2. Agudelo, C.F. Cystic Endometrial Hyperplasia-pyometra Complex in Cats. A Review. Vet. Q. 2005, 27, 173–182. [Google Scholar] [CrossRef]
  3. Hollinshead, F.; Krekeler, N. Pyometra in the Queen: To Spay or Not to Spay? J. Feline Med. Surg. 2016, 18, 21–33. [Google Scholar] [CrossRef] [PubMed]
  4. DOW, C. The Cystic Hyperplasia-Pyometra Complex in the Bitch. J. Comp. Pathol. 1959, 69, 237–250. [Google Scholar] [CrossRef]
  5. Hagman, R. Pyometra in Small Animals. Vet. Clin. N. Am. Small Anim. Pract. 2018, 48, 639–661. [Google Scholar] [CrossRef] [PubMed]
  6. Nak, D.; Misirlioglu, D.; Nak, Y.; Keskin, A. Clinical Laboratory Findings, Vaginal Cytology and Pathology in a Controlled Study of Pyometra in Cats. Aust. Vet. Pract. 2005, 35, 10–14. [Google Scholar]
  7. Rautela, R.; Katiyar, R. Review on Canine Pyometra, Oxidative Stress and Current Trends in Diagnostics. Asian Pac. J. Reprod. 2019, 8, 45–55. [Google Scholar] [CrossRef]
  8. Johnson, A. Diagnosis and Medical Treatment of Pyometra in the Queen. Clin. Theriogenol. 2022, 14, 151–154. [Google Scholar] [CrossRef]
  9. Demirel, M.A.; Acar, D.B. Ovarian Remnant Syndrome and Uterine Stump Pyometra in Three Queens. J. Feline Med. Surg. 2012, 14, 913–918. [Google Scholar] [CrossRef]
  10. Pailler, S.; Dolan, E.D.; Slater, M.R.; Gayle, J.M.; Lesnikowski, S.M.; DeClementi, C. Owner-Reported Long-Term Outcomes, Quality of Life, and Longevity after Hospital Discharge Following Surgical Treatment of Pyometra in Bitches and Queens. J. Am. Vet. Med. Assoc. 2022, 260, S57–S63. [Google Scholar] [CrossRef]
  11. Pailler, S.; Slater, M.R.; Lesnikowski, S.M.; Gayle, J.M.; Duvieusart, C.B.C.A.; Ledesma, E.J.; Lee, M.L.; Stevens, J.D.; DeClementi, C. Findings and Prognostic Indicators of Outcomes for Bitches with Pyometra Treated Surgically in a Nonspecialized Setting. J. Am. Vet. Med. Assoc. 2022, 260, S49–S56. [Google Scholar] [CrossRef] [PubMed]
  12. Fontbonne, A. Infertility in Queens: Clinical Approach, Experiences and Challenges. J. Feline Med. Surg. 2022, 24, 825–836. [Google Scholar] [CrossRef] [PubMed]
  13. Nascimento, A.E.d.J.; Santos, L.C.; Santos, B.R.; Santos, E.O.; Cunha, M.C.d.S.G.; Snoeck, P.P.d.N.; de Lavor, M.S.L.; Silva, J.F. Estrogen and Progesterone Receptors and Antioxidant Enzymes Are Expressed Differently in the Uterus of Domestic Cats during the Estrous Cycle. Theriogenology 2023, 203, 1–10. [Google Scholar] [CrossRef] [PubMed]
  14. Nascimento, A.E.d.J.; Santos, L.C.; Santos, B.R.; Santos, E.O.; Cunha, M.C.d.S.G.; Snoeck, P.P.d.N.; de Lavor, M.S.L.; Silva, J.F. Pyometra Alters the Redox Status and Expression of Estrogen and Progesterone Receptors in the Uterus of Domestic Cats. J. Feline Med. Surg. 2023, 25, 1098612X231170159. [Google Scholar] [CrossRef]
  15. Santos, L.C.; Silva, J.F. Molecular Factors Involved in the Reproductive Morphophysiology of Female Domestic Cat (Felis catus). Animals 2023, 13, 3153. [Google Scholar] [CrossRef] [PubMed]
  16. Andrews, C.J.; Thomas, D.G.; Yapura, J.; Potter, M.A. Reproductive Biology of the 38 Extant Felid Species: A Review. Mammal Rev. 2019, 49, 16–30. [Google Scholar] [CrossRef]
  17. Griffin, B. Prolific Cats: The Estrous Cycle. Compend. Contin. Educ. Pract. Vet. 2001, 23, 1049–1056. [Google Scholar]
  18. Johnson, A.K. Normal Feline Reproduction: The Queen. J. Feline Med. Surg. 2022, 24, 204–211. [Google Scholar] [CrossRef]
  19. Da Silva, T.F.P.; da Silva, L.D.M.; Uchoa, D.C.; Monteiro, C.L.B.; Thomaz, L.d.A. Sexual Characteristics of Domestic Queens Kept in a Natural Equatorial Photoperiod. Theriogenology 2006, 66, 1476–1481. [Google Scholar] [CrossRef]
  20. Ferré-Dolcet, L.; Yeste, M.; Vendrell, M.; Rigau, T.; Rodríguez-Gil, J.E.; del Álamo, M.M.R. Placental and Uterine Expression of GLUT3, but Not GLUT1, Is Related with Serum Progesterone Levels during the First Stages of Pregnancy in Queens. Theriogenology 2018, 121, 82–90. [Google Scholar] [CrossRef]
  21. Veiga, G.A.L.; Miziara, R.H.; Angrimani, D.S.R.; Papa, P.C.; Cogliati, B.; Vannucchi, C.I. Cystic Endometrial Hyperplasia-Pyometra Syndrome in Bitches: Identification of Hemodynamic, Inflammatory, and Cell Proliferation Changes. Biol. Reprod. 2017, 96, 58–69. [Google Scholar] [CrossRef] [PubMed]
  22. Schlafer, D.H.; Gifford, A.T. Cystic Endometrial Hyperplasia, Pseudo-Placentational Endometrial Hyperplasia, and Other Cystic Conditions of the Canine and Feline Uterus. Theriogenology 2008, 70, 349–358. [Google Scholar] [CrossRef] [PubMed]
  23. Santos, L.C.; dos Anjos Cordeiro, J.M.; da Silva Santana, L.; Santana, L.R.; Santos, B.R.; Barbosa, E.M.; da Silva, T.Q.M.; Corrêa, J.M.X.; Lavor, M.S.L.; da Silva, E.B.; et al. Pyometra and Estrous Cycle Modulate the Uterine Expression of the Kisspeptin System and Angiogenic and Immune Factors in Cats. Biol. Reprod. 2021, 104, 548–561. [Google Scholar] [CrossRef]
  24. Yaseen, A.; Kareem, D.; Waheed, Z.; Fahad, T. Histopathological Study of Some Abnormalities of Infertility in the Queens. Basrah J. Vet. Res. 2022, 21, 131–140. [Google Scholar] [CrossRef]
  25. Santana, C.H.; Santos, D.O.; Trindade, L.M.; Moreira, L.G.; Paixão, T.A.; Santos, R.L. Association of Pseudoplacentational Endometrial Hyperplasia and Pyometra in Dogs. J. Comp. Pathol. 2020, 180, 79–85. [Google Scholar] [CrossRef]
  26. Hagman, R.; Ström Holst, B.; Möller, L.; Egenvall, A. Incidence of Pyometra in Swedish Insured Cats. Theriogenology 2014, 82, 114–120. [Google Scholar] [CrossRef]
  27. Musleh Uddin, A. Pyometra in a Cat: A Clinical Case Report. Biomed. J. Sci. Tech. Res. 2021, 37, 29851–29856. [Google Scholar] [CrossRef]
  28. Binder, C.; Aurich, C.; Reifinger, M.; Aurich, J. Spontaneous Ovulation in Cats—Uterine Findings and Correlations with Animal Weight and Age. Anim. Reprod. Sci. 2019, 209, 106167. [Google Scholar] [CrossRef]
  29. Prapaiwan, N.; Manee-in, S.; Olanratmanee, E.; Srisuwatanasagul, S. Expression of Oxytocin, Progesterone, and Estrogen Receptors in the Reproductive Tract of Bitches with Pyometra. Theriogenology 2017, 89, 131–139. [Google Scholar] [CrossRef]
  30. Misk, T.N.; El-Sherry, T.M. Pyometra in Cats: Medical Versus Surgical Treatment. J. Curr. Vet. Res. 2020, 2, 86–92. [Google Scholar] [CrossRef]
  31. Pereira, M.C.; Schrank, M.; Mollo, A.; Romagnoli, S. Spontaneous Ovulation in the Cat: Incidence among Queens Presented at a Veterinary Teaching Facility. J. Feline Med. Surg. 2024, 26, 1–7. [Google Scholar] [CrossRef] [PubMed]
  32. Romagnoli, S.; Bensaia, C.; Ferré-Dolcet, L.; Sontas, H.B.; Stelletta, C. Fertility Parameters and Reproductive Management of Norwegian Forest Cats, Maine Coon, Persian and Bengal Cats Raised in Italy: A Questionnaire-Based Study. J. Feline Med. Surg. 2019, 21, 1188–1197. [Google Scholar] [CrossRef] [PubMed]
  33. Holst, B.S. Feline Breeding and Pregnancy Management: What Is Normal and When to Intervene. J. Feline Med. Surg. 2022, 24, 221–231. [Google Scholar] [CrossRef]
  34. Szczubiał, M.; Wawrzykowski, J.; Dąbrowski, R.; Bochniarz, M.; Brodzki, P.; Kankofer, M. The Effect of Pyometra on Glycosylation of Proteins in the Uterine Tissues from Female Dogs. Theriogenology 2019, 131, 41–46. [Google Scholar] [CrossRef] [PubMed]
  35. Lopes, C.E.; De Carli, S.; Riboldi, C.I.; De Lorenzo, C.; Panziera, W.; Driemeier, D.; Siqueira, F.M. Pet Pyometra: Correlating Bacteria Pathogenicity to Endometrial Histological Changes. Pathogens 2021, 10, 833. [Google Scholar] [CrossRef]
  36. Zheng, H.H.; Du, C.T.; Zhang, Y.Z.; Yu, C.; Huang, R.L.; Tang, X.Y.; Xie, G.H. A Study on the Correlation between Intrauterine Microbiota and Uterine Pyogenesis in Dogs. Theriogenology 2023, 196, 97–105. [Google Scholar] [CrossRef] [PubMed]
  37. Szczubiał, M.; Kankofer, M.; Wawrzykowski, J.; Dąbrowski, R.; Bochniarz, M.; Brodzki, P. Activity of the Glycosidases β-Galactosidase, α-L-Fucosidase, β-N-Acetyl-Hexosaminidase, and Sialidase in Uterine Tissues from Female Dogs in Diestrus with and without Pyometra. Theriogenology 2022, 177, 133–139. [Google Scholar] [CrossRef]
  38. Marinković, D.; Aničić, M.; Vakanjac, S.; Nedić, S.; Magaš, V. Morphological Characteristics and Expression of Estrogen and Progesterone Receptors in the Canine Endometrium during the Estrus Cycle, Cystic Endometrial Hyperplasia and Pyometra. Acta Vet. Brno. 2018, 68, 239–250. [Google Scholar] [CrossRef]
  39. Tiptanavattana, N.; Khirilak, P.; Tharasanit, T.; Duangtum, N.; Jankaew, K.; Sae-Jia, P.; Kaewchana, N. Expression of Prostaglandin F2 Alpha Receptors (PTGFR) and C-Reactive Protein (CRP) in the Canine Uterus and Cervix with Opened- and Closed-Cervix Pyometra. Thai J. Vet. Med. 2022, 52, 45–56. [Google Scholar] [CrossRef]
  40. De Bosschere, H.; Ducatelle, R.; Tshamala, M. Uterine Oestrogen and Progesterone Receptor Expression in Experimental Pyometra in the Bitch. J. Comp. Pathol. 2003, 128, 99–106. [Google Scholar] [CrossRef]
  41. Lopes, C.E.; De Carli, S.; Weber, M.N.; Fonseca, A.C.V.; Tagliari, N.J.; Foresti, L.; Cibulski, S.P.; Mayer, F.Q.; Canal, C.W.; Siqueira, F.M. Insights on the Genetic Features of Endometrial Pathogenic Escherichia Coli Strains from Pyometra in Companion Animals: Improving the Knowledge about Pathogenesis. Infect. Genet. Evol. 2020, 85, 104453. [Google Scholar] [CrossRef] [PubMed]
  42. Niewiadomska, Z.; Adib-Lesaux, A.; Reyes-Gomez, E.; Gandoin, C.; Bouillin, C.; Gaillard, V.; Fontbonne, A. Uterine Issues in Infertile Queens: Nine Cases. Anim. Reprod. Sci. 2023, 251, 107225. [Google Scholar] [CrossRef] [PubMed]
  43. Santos, L.C.; Cordeiro, J.M.d.A.; Santana, L.d.S.; Barbosa, E.M.; Santos, B.R.; Silva, T.Q.M.d.; Souza, S.S.d.; Corrêa, J.M.X.; Lavor, M.S.L.; Silva, E.B.d.; et al. Expression Profile of the Kisspeptin/Kiss1r System and Angiogenic and Immunological Mediators in the Ovary of Cyclic and Pregnant Cats. Domest. Anim. Endocrinol. 2022, 78, 106650. [Google Scholar] [CrossRef] [PubMed]
  44. Hirota, Y. Progesterone Governs Endometrial Proliferationdifferentiation Switching and Blastocyst Implantation. Endocr. J. 2019, 66, 199–206. [Google Scholar] [CrossRef]
  45. Abdelbaset, Z.; Sosa, G.; Abdel-Ghaffar, A.; Kandiel, M. Predictive Markers and Risk Factors in Canine and Feline Pyometra under Egyptian Conditions. Benha Vet. Med. J. 2022, 42, 170–175. [Google Scholar] [CrossRef]
  46. Gultiken, N.; Yarim, M.; Yarim, G.F.; Gacar, A.; Mason, J.I. Expression of 3β-Hydroxysteroid Dehydrogenase in Ovarian and Uterine Tissue during Diestrus and Open Cervix Cystic Endometrial Hyperplasia-Pyometra in the Bitch. Theriogenology 2015, 86, 572–578. [Google Scholar] [CrossRef]
  47. Misirlioglu, D.; Nak, D.; Sevimli, A.; Nak, Y.; Ozyigit, M.O.; Akkoc, A.; Cangul, I.T. Steroid Receptor Expression and HER-2/Neu (c-ErbB-2) Oncoprotein in the Uterus of Cats with Cystic Endometrial Hyperplasia-Pyometra Complex. J. Vet. Med. Ser. A Physiol. Pathol. Clin. Med. 2006, 53, 225–229. [Google Scholar] [CrossRef] [PubMed]
  48. De Bosschere, H.; Ducatelle, R.; Vermeirsch, H.; Simoens, P.; Coryn, M. Estrogen-α and Progesterone Receptor Expression in Cystic Endometrial Hyperplasia and Pyometra in the Bitch. Anim. Reprod. Sci. 2002, 70, 251–259. [Google Scholar] [CrossRef]
  49. Mueller, S.O.; Korach, K.S. Estrogen Receptors and Endocrine Diseases: Lessons from Estrogen Receptor Knockout Mice. Curr. Opin. Pharmacol. 2001, 1, 613–619. [Google Scholar] [CrossRef]
  50. Kovats, S. Estrogen Receptors Regulate Innate Immune Cells and Signaling Pathways. Cell. Immunol. 2015, 294, 63–69. [Google Scholar] [CrossRef]
  51. Chang, C.; Lee, S.O.; Wang, R.S.; Yeh, S.; Chang, T.M. Androgen Receptor (AR) Physiological Roles in Male and Female Reproductive Systems: Lessons Learned from AR-Knockout Mice Lacking AR in Selective Cells. Biol. Reprod. 2013, 89, 21. [Google Scholar] [CrossRef]
  52. Vermeirsch, H.; Van den Broeck, W.; Coryn, M.; Simoens, P. Immunohistochemical Detection of Androgen Receptors in the Canine Uterus throughout the Estrus Cycle. Theriogenology 2002, 57, 2203–2216. [Google Scholar] [CrossRef] [PubMed]
  53. Amelkina, O.; Zschockelt, L.; Painer, J.; Serra, R.; Villaespesa, F.; Krause, E.; Jewgenow, K.; Braun, B.C. Progesterone, Estrogen, and Androgen Receptors in the Corpus Luteum of the Domestic Cat, Iberian Lynx (Lynx pardinus) and Eurasian Lynx (Lynx lynx). Theriogenology 2016, 86, 2107–2118. [Google Scholar] [CrossRef] [PubMed]
  54. Amelkina, O.; Tanyapanyachon, P.; Thongphakdee, A.; Chatdarong, K. Identification of Feline Kiss1 and Distribution of Immunoreactive Kisspeptin in the Hypothalamus of the Domestic Cat. J. Reprod. Dev. 2019, 65, 335–343. [Google Scholar] [CrossRef] [PubMed]
  55. Tanyapanyachon, P.; Amelkina, O.; Chatdarong, K. The Expression of Kisspeptin and Its Receptor in the Domestic Cat Ovary and Uterus in Different Stages of the Ovarian Cycle. Theriogenology 2018, 117, 40–48. [Google Scholar] [CrossRef]
  56. Santos, L.C.; dos Anjos Cordeiro, J.M.; da Silva Santana, L.; Santos, B.R.; Barbosa, E.M.; da Silva, T.Q.M.; Corrêa, J.M.X.; Niella, R.V.; Lavor, M.S.L.; da Silva, E.B.; et al. Kisspeptin/Kiss1r System and Angiogenic and Immunological Mediators at the Maternal-Fetal Interface of Domestic Cats. Biol. Reprod. 2021, 105, 217–231. [Google Scholar] [CrossRef]
  57. Zhang, P.; Tang, M.; Zhong, T.; Lin, Y.; Zong, T.; Zhong, C.; Zhang, B.P.; Ren, M.; Kuang, H. Bin Expression and Function of Kisspeptin during Mouse Decidualization. PLoS ONE 2014, 9, e97647. [Google Scholar] [CrossRef]
  58. León, S.; Fernadois, D.; Sull, A.; Sull, J.; Calder, M.; Hayashi, K.; Bhattacharya, M.; Power, S.; Vilos, G.A.; Vilos, A.G.; et al. Beyond the Brain-Peripheral Kisspeptin Signaling Is Essential for Promoting Endometrial Gland Development and Function. Sci. Rep. 2016, 6, 29073. [Google Scholar] [CrossRef]
  59. Schaefer, J.; Vilos, A.G.; Vilos, G.A.; Bhattacharya, M.; Babwah, A.V. Uterine Kisspeptin Receptor Critically Regulates Epithelial Estrogen Receptor α Transcriptional Activity at the Time of Embryo Implantation in a Mouse Model. Mol. Hum. Reprod. 2021, 27, gaab060. [Google Scholar] [CrossRef]
  60. Kurt, S.; Eşki, F.; Mis, L. Investigation of the Usability of Kisspeptin and Oxidative Stress Parameters in the Early Diagnosis of Asymptomatic Cystic Endometrial Hyperplasia in Dogs. Reprod. Domest. Anim. 2021, 56, 1529–1535. [Google Scholar] [CrossRef]
  61. Yang, Y.; Song, S.; Gu, S.; Gu, Y.; Zhao, P.; Li, D.; Cheng, W.; Liu, C.; Zhang, H. Kisspeptin Prevents Pregnancy Loss by Modulating the Immune Microenvironment at the Maternal-Fetal Interface in Recurrent Spontaneous Abortion. Am. J. Reprod. Immunol. 2024, 91, e13818. [Google Scholar] [CrossRef] [PubMed]
  62. Gorbunova, O.L.; Shirshev, S.V. Role of Kisspeptin in Regulation of Reproductive and Immune Reactions. Biochemistry 2020, 85, 839–853. [Google Scholar] [CrossRef] [PubMed]
  63. Zhang, J.; Jin, L.; Kong, L.; Nie, L.; Yuan, D. Physiological and Pathological Roles of Locally Expressed Kisspeptin and KISS1R in the Endometrium. Hum. Reprod. 2023, 38, 1253–1260. [Google Scholar] [CrossRef] [PubMed]
  64. Liu, N.; Yang, H.; Han, L.; Ma, M. Oxytocin in Women’s Health and Disease. Front. Endocrinol. 2022, 13, 786271. [Google Scholar] [CrossRef] [PubMed]
  65. Tamminen, T.; Sahlin, L.; Masironi-Malm, B.; Dahlbom, M.; Katila, T.; Taponen, J.; Laitinen-Vapaavuori, O. Expression of Uterine Oxytocin Receptors and Blood Progesterone, 13,14-Dihydro-15-Keto-Prostaglandin F2α, and Ionized Calcium Levels in Dystocic Bitches. Theriogenology 2019, 135, 38–45. [Google Scholar] [CrossRef]
  66. Siemieniuch, M.J.; Mlynarczuk, J.J.; Skarzynski, D.J.; Okuda, K. Possible Involvement of Oxytocin and Its Receptor in the Local Regulation of Prostaglandin Secretion in the Cat Endometrium. Anim. Reprod. Sci. 2011, 123, 89–97. [Google Scholar] [CrossRef]
  67. Talat Naoman, U. Causes and Treatment of Feline Dystocia. J. Appl. Vet. Sci. 2021, 6, 28–31. [Google Scholar] [CrossRef]
  68. Sasidharan, J.K.; Patra, M.K.; Khan, J.A.; Singh, A.K.; Karikalan, M.; De, U.K.; Saxena, A.C.; Dubal, Z.B.; Singh, S.K.; Kumar, H.; et al. Differential Expression of Inflammatory Cytokines, Prostaglandin Synthases and Secretory Leukocyte Protease Inhibitor in the Endometrium and Circulation in Different Graded CEH-Pyometra in Bitch. Theriogenology 2023, 197, 139–149. [Google Scholar] [CrossRef]
  69. Zhang, J.-M.; An, J. Cytokines, Inflammation, and Pain. Int. Anesthesiol. Clin. 2007, 45, 27–37. [Google Scholar] [CrossRef]
  70. Abdelnaby, E.A.; Alhaider, A.K.; Ghoneim, I.M.; Salem, N.Y.; Ramadan, E.S.; Farghali, H.A.; Khattab, M.S.; AbdElKader, N.A.; Emam, I.A. Effect of Pyometra on Vascularity Alterations, Oxidative Stress, Histopathology and Inflammatory Molecules in Feline. Reprod. Biol. 2024, 24, 100855. [Google Scholar] [CrossRef]
  71. Lu, J.; Wang, Z.; Cao, J.; Chen, Y.; Dong, Y. A Novel and Compact Review on the Role of Oxidative Stress in Female Reproduction. Reprod. Biol. Endocrinol. 2018, 16, 80. [Google Scholar] [CrossRef]
  72. Jursza, E.; Szóstek, A.Z.; Kowalewski, M.P.; Boos, A.; Okuda, K.; Siemieniuch, M.J. LPS-Challenged TNF α Production, Prostaglandin Secretion, and TNF α /TNFRs Expression in the Endometrium of Domestic Cats in Estrus or Diestrus, and in Cats with Pyometra or Receiving Medroxyprogesterone Acetate. Mediat. Inflamm. 2014, 2014, 689280. [Google Scholar] [CrossRef]
  73. Jursza-Piotrowska, E.; Socha, P.; Skarzynski, D.J.; Siemieniuch, M.J. Prostaglandin Release by Cultured Endometrial Tissues after Challenge with Lipopolysaccharide and Tumor Necrosis Factor α, in Relation to the Estrous Cycle, Treatment with Medroxyprogesterone Acetate, and Pyometra. Theriogenology 2016, 85, 1177–1185. [Google Scholar] [CrossRef]
  74. Jursza-Piotrowska, E.; Siemieniuch, M.J. Comparison of the Effect of Lipopolysaccharide on Tumor Necrosis Factor α (TNF-α) Secretion and TNF and TNFR1 MRNA Levels in Feline Endometrium throughout the Estrous Cycle during Pyometra and after Medroxyprogesterone Acetate Treatment. J. Reprod. Dev. 2016, 62, 385–391. [Google Scholar] [CrossRef]
  75. Chotimanukul, S.; Sirivaidyapong, S. Differential Expression of Toll-like Receptor 4 (TLR4) in Healthy and Infected Canine Endometrium. Theriogenology 2011, 76, 1152–1161. [Google Scholar] [CrossRef]
  76. Jursza, E.; Kowalewski, M.P.; Boos, A.; Skarzynski, D.J.; Socha, P.; Siemieniuch, M.J. The Role of Toll-like Receptors 2 and 4 in the Pathogenesis of Feline Pyometra. Theriogenology 2015, 83, 596–603. [Google Scholar] [CrossRef]
  77. Jursza-Piotrowska, E.; Siemieniuch, M.J. Identifying Diagnostic Endocrine Markers and Changes in Endometrial Gene Expressions during Pyometra in Cats. Reprod. Biol. 2016, 16, 174–180. [Google Scholar] [CrossRef]
  78. Yount, S.M.; Lassiter, N. The Pharmacology of Prostaglandins for Induction of Labor. J. Midwifery Womens. Health 2013, 58, 133–144. [Google Scholar] [CrossRef]
  79. Konturek, S.J.; Pawlik, W. Physiology and Pharmacology of Prostaglandins. Dig. Dis. Sci. 1986, 31, 6S–19S. [Google Scholar] [CrossRef]
  80. Hagman, R.; Karlstam, E.; Persson, S.; Kindahl, H. Plasma PGF2α Metabolite Levels in Cats with Uterine Disease. Theriogenology 2009, 72, 1180–1187. [Google Scholar] [CrossRef]
  81. Romagnoli, S.; Ferre-Dolcet, L. Reversible Control of Reproduction In Queens: Mastering the Use of Reproductive Drugs to Manipulate Cyclicity. J. Feline Med. Surg. 2022, 24, 853–870. [Google Scholar] [CrossRef]
  82. Al-Zubaidi, S.F.; Alneamah, G.A.A.; Mahdi, A.S.; Wali, A.A. Pyometra Treatment in Bitches with Different Protocols. Adv. Anim. Vet. Sci. 2024, 12, 120–124. [Google Scholar] [CrossRef]
  83. Singh, L.K.; Patra, M.K.; Mishra, G.K.; Singh, V.; Upmanyu, V.; Saxena, A.C.; Singh, S.K.; Das, G.K.; Kumar, H.; Krishnaswamy, N. Endometrial Transcripts of Proinflammatory Cytokine and Enzymes in Prostaglandin Synthesis Are Upregulated in the Bitches with Atrophic Pyometra. Vet. Immunol. Immunopathol. 2018, 205, 65–71. [Google Scholar] [CrossRef]
  84. Tamada, H.; Adachi, N.; Kawate, N.; Inaba, T.; Hatoya, S.; Sawada, T. Positive Correlation between Patency and MRNA Levels for Cyclooxygenase-2 and Prostaglandin E Synthase in the Uterine Cervix of Bitches with Pyometra. J. Vet. Med. Sci. 2016, 78, 525–528. [Google Scholar] [CrossRef][Green Version]
  85. Saraiva, A.L.; Payan-Carreira, R.; Gärtner, F.; Santana, I.; Rêma, A.; Lourenço, L.M.; Pires, M.A. Immunohistochemical Expression of Cyclooxygenase-2 (COX-2) in Feline Endometrial Adenocarcinoma and in Normal and Hyperplastic Endometria. Reprod. Domest. Anim. 2015, 50, 333–340. [Google Scholar] [CrossRef]
  86. Kempisty, B.; Bukowska, D.; Wozna, M.; Piotrowska, H.; Jackowska, M.; Zuraw, A.; Ciesiolka, S.; Antosik, P.; Maryniak, H.; Ociepa, E.; et al. Endometritis and Pyometra in Bitches: A Review. Vet. Med. 2013, 58, 289–297. [Google Scholar] [CrossRef]
  87. Kida, K.; Maezono, Y.; Kawate, N.; Inaba, T.; Hatoya, S.; Tamada, H. Epidermal Growth Factor, Transforming Growth Factor-α, and Epidermal Growth Factor Receptor Expression and Localization in the Canine Endometrium during the Estrous Cycle and in Bitches with Pyometra. Theriogenology 2010, 73, 36–47. [Google Scholar] [CrossRef]
  88. Kim, M.; Park, H.J.; Seol, J.W.; Jang, J.Y.; Cho, Y.S.; Kim, K.R.; Choi, Y.; Lydon, J.P.; Demayo, F.J.; Shibuya, M.; et al. VEGF-A Regulated by Progesterone Governs Uterine Angiogenesis and Vascular Remodelling during Pregnancy. EMBO Mol. Med. 2013, 5, 1415–1430. [Google Scholar] [CrossRef]
  89. Autiero, M.; Luttun, A.; Tjwa, M.; Carmeliet, P. Placental Growth Factor and Its Receptor, Vascular Endothelial Growth Factor Receptor-1: Novel Targets for Stimulation of Ischemic Tissue Revascularization and Inhibition of Angiogenic and Inflammatory Disorders. J. Thromb. Haemost. 2003, 1, 1356–1370. [Google Scholar] [CrossRef]
  90. Massagué, J. TGFβ Signalling in Context. Nat. Rev. Mol. Cell Biol. 2012, 13, 616–630. [Google Scholar] [CrossRef]
  91. Boomsma, R.A.; Mavrogianis, P.A.; Verhage, H.G. Immunocytochemical Localization of Transforming Growth Factor α, Epidermal Growth Factor and Epidermal Growth Factor Receptor in the Cat Endometrium and Placenta. Histochem. J. 1997, 29, 495–504. [Google Scholar] [CrossRef]
  92. Sabbah, D.A.; Hajjo, R.; Sweidan, K. Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors. Curr. Top. Med. Chem. 2020, 20, 815–834. [Google Scholar] [CrossRef]
  93. Rybska, M.; Woźna-Wysocka, M.; Wąsowska, B.; Skrzypski, M.; Kubiak, M.; Błaszak, B.; Łukomska, A.; Nowak, T.; Jaśkowski, J.M. Expression of Transforming Growth Factor Beta Isoforms in Canine Endometrium with Cystic Endometrial Hyperplasia–Pyometra Complex. Animals 2021, 11, 1844. [Google Scholar] [CrossRef]
  94. Vilhena, H.; Figueiredo, M.; Cerón, J.; Pastor, J.; Miranda, S.; Craveiro, H.; Pires, M.A.; Tecles, F.; Rubio, C.P.; Dabrowski, R.; et al. Acute Phase Proteins and Antioxidant Responses in Queens with Pyometra. Theriogenology 2018, 115, 30–37. [Google Scholar] [CrossRef]
  95. Nandi, A.; Yan, L.J.; Jana, C.K.; Das, N. Role of Catalase in Oxidative Stress- And Age-Associated Degenerative Diseases. Oxid. Med. Cell. Longev. 2019, 2019, 9613090. [Google Scholar] [CrossRef]
  96. Dandekar, A.; Mendez, R.; Zhang, K. Cross Talk Between ER Stress, Oxidative Stress, and Inflammation in Health and Disease. In Stress Responses: Methods and Protocols; Humana Press: Totowa, NJ, USA, 2015; Volume 1292, pp. 205–214. ISBN 9781493925223. [Google Scholar]
  97. Del Rio, D.; Stewart, A.J.; Pellegrini, N. A Review of Recent Studies on Malondialdehyde as Toxic Molecule and Biological Marker of Oxidative Stress. Nutr. Metab. Cardiovasc. Dis. 2005, 15, 316–328. [Google Scholar] [CrossRef]
  98. Tsikas, D. Assessment of Lipid Peroxidation by Measuring Malondialdehyde (MDA) and Relatives in Biological Samples: Analytical and Biological Challenges. Anal. Biochem. 2017, 524, 13–30. [Google Scholar] [CrossRef]
  99. Ighodaro, O.M.; Akinloye, O.A. First Line Defence Antioxidants-Superoxide Dismutase (SOD), Catalase (CAT) and Glutathione Peroxidase (GPX): Their Fundamental Role in the Entire Antioxidant Defence Grid. Alex. J. Med. 2018, 54, 287–293. [Google Scholar] [CrossRef]
  100. Santos, C.; Pires, M.d.A.; Santos, D.; Payan-Carreira, R. Distribution of Superoxide Dismutase 1 and Glutathione Peroxidase 1 in the Cyclic Canine Endometrium. Theriogenology 2016, 86, 738–748. [Google Scholar] [CrossRef]
  101. Azadmanesh, J.; Borgstahl, G.E.O. A Review of the Catalytic Mechanism of Human Manganese Superoxide Dismutase. Antioxidants 2018, 7, 25. [Google Scholar] [CrossRef]
  102. Yazlık, M.O.; Mutluer, İ.; Kaya, U.; Özkan, H.; Müştak, İ.B.; Çolakoğlu, H.E.; Altınbaş, Y.F.; Vural, M.R. The Role of Nutritional-Immunological Indices in Estimating Serum LPS and Antioxidant Enzyme Activity and Sepsis Status in Female Dogs with Pyometra Caused by E. Coli. Anim. Reprod. Sci. 2023, 255, 107276. [Google Scholar] [CrossRef] [PubMed]
  103. Yang, M.S.; Chan, H.W.; Yu, L.C. Glutathione Peroxidase and Glutathione Reductase Activities Are Partially Responsible for Determining the Susceptibility of Cells to Oxidative Stress. Toxicology 2006, 226, 126–130. [Google Scholar] [CrossRef] [PubMed]
  104. Nascimento, A.E.d.J.; Santos, L.C.; Santos, B.R.; Santos, E.O.; Cunha, M.C.d.S.G.; Snoeck, P.P.d.N.; de Lavor, M.S.L.; Silva, J.F. Spatial and Temporal Expression Profile of Sex Steroid Receptors and Antioxidant Enzymes in the Maternal-Fetal Interface of Domestic Cats. Theriogenology 2023, 210, 234–243. [Google Scholar] [CrossRef]
  105. Rossi, G. Acute Phase Proteins in Cats: Diagnostic and Prognostic Role, Future Directions, and Analytical Challenges. Vet. Clin. Pathol. 2023, 52, 37–49. [Google Scholar] [CrossRef]
  106. Hagman, R.; Rönnberg, E.; Pejler, G. Canine Uterine Bacterial Infection Induces Upregulation of Proteolysis-Related Genes and Downregulation of Homeobox and Zinc Finger Factors. PLoS ONE 2009, 4, e8039. [Google Scholar] [CrossRef]
  107. Cerón, J.J.; Eckersall, P.D.; Martínez-Subiela, S. Acute Phase Proteins in Dogs and Cats: Current Knowledge and Future Perspectives. Vet. Clin. Pathol. 2005, 34, 85–99. [Google Scholar] [CrossRef]
  108. Donato, G.; Pennisi, M.G.; Persichetti, M.F.; Archer, J.; Masucci, M. A Retrospective Comparative Evaluation of Selected Blood Cell Ratios, Acute Phase Proteins, and Leukocyte Changes Suggestive of Inflammation in Cats. Animals 2023, 13, 2579. [Google Scholar] [CrossRef] [PubMed]
  109. Trumel, C.; Gaillard, E.; Leynaud, V.; Aumann, M.; Braun, J.P. Comparison of the Diagnostic Accuracy of Markers of the Acute Phase of Inflammation in Cats. A Preliminary Evaluation. Comp. Clin. Path. 2019, 28, 505–511. [Google Scholar] [CrossRef]
  110. Hadžimusić, N.; Livnjak, A.; Velić, L. Some Acute Phase Proteins and Biochemistry Parameters of Female Dogs Affected with Pyometra. Annu. Res. Rev. Biol. 2024, 39, 41–47. [Google Scholar] [CrossRef]
  111. Kann, R.K.C.; Seddon, J.M.; Henning, J.; Meers, J. Acute Phase Proteins in Healthy and Sick Cats. Res. Vet. Sci. 2012, 93, 649–654. [Google Scholar] [CrossRef]
  112. Rosa, R.M.; Mestrinho, L.A.P. Acute Phase Proteins in Cats. Cienc. Rural 2019, 49, e20180790. [Google Scholar] [CrossRef]
  113. Jitpean, S.; Pettersson, A.; Höglund, O.V.; Holst, B.S.; Olsson, U.; Hagman, R. Increased Concentrations of Serum Amyloid A in Dogs with Sepsis Caused by Pyometra. BMC Vet. Res. 2014, 10, 273. [Google Scholar] [CrossRef] [PubMed]
  114. El-Bahr, S.M.; El-Deeb, W.M. Acute-Phase Proteins, Oxidative Stress Biomarkers, Proinflammatory Cytokines, and Cardiac Troponin in Arabian Mares Affected with Pyometra. Theriogenology 2016, 86, 1132–1136. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.